Literature DB >> 20213845

A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population.

M Bowman1, W M Hopman, D Rapson, D Lillicrap, M Silva, P James.   

Abstract

The prevalence of von Willebrand disease (VWD) is reported as approximately 1%; however, these estimates were not based on individuals with significant symptoms. Four thousand five hundred ninety-two unselected parents/children were asked: "Does your child have a problem with bleeding/bruising?"; 223 (5%) answered yes, 41 of whom were administered the validated Pediatric Bleeding Questionnaire and had VWF testing. Five were diagnosed with VWD (three type 1, one type 2A, one type 2B). The prevalence of bleeding/bruising in a general pediatric population is 5%; the prevalence of symptomatic VWD at the level of pediatric primary care is at least 1 in 1,000.

Entities:  

Mesh:

Year:  2010        PMID: 20213845     DOI: 10.1002/pbc.22429

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  An international survey to inform priorities for new guidelines on von Willebrand disease.

Authors:  Mohamad A Kalot; Mohammed Al-Khatib; Nathan T Connell; Veronica Flood; Romina Brignardello-Petersen; Paula James; Reem A Mustafa
Journal:  Haemophilia       Date:  2019-11-26       Impact factor: 4.287

2.  Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.

Authors:  M Deforest; J Grabell; S Albert; J Young; A Tuttle; W M Hopman; P D James
Journal:  Haemophilia       Date:  2015-07-14       Impact factor: 4.287

3.  Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.

Authors:  Soundarya N Selvam; Lara J Casey; Mackenzie L Bowman; Lindsey G Hawke; Avery J Longmore; Jeffrey Mewburn; Mark L Ormiston; Stephen L Archer; Donald H Maurice; Paula James
Journal:  Blood Coagul Fibrinolysis       Date:  2017-10       Impact factor: 1.276

4.  Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children.

Authors:  N Mittal; R Naridze; P James; S Shott; L A Valentino
Journal:  Haemophilia       Date:  2015-05-16       Impact factor: 4.287

Review 5.  Women and bleeding disorders: diagnostic challenges.

Authors:  Paula D James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 6.  von Willebrand disease.

Authors:  Paula D James; Anne C Goodeve
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

7.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

Review 8.  The bleeding child. Part I: primary hemostatic disorders.

Authors:  C Heleen van Ommen; Marjolein Peters
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

9.  Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease.

Authors:  Karon Abe; Brandi Dupervil; Sarah H O'Brien; Meredith Oakley; Roshni Kulkarni; Joan Cox Gill; Vanessa Byams; Michael J Soucie
Journal:  Am J Hematol       Date:  2019-10-29       Impact factor: 13.265

10.  Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey.

Authors:  Mark T Reding; David L Cooper
Journal:  J Multidiscip Healthc       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.